AI Deployment Services for Clinical Trials
Maxis AI offers Forward Deployment Engineering to solve high impact problems in Clinical Trials for our partners . Our deployment engineers work directly with customers to solve their specific problems, validate impact, and then identify patterns that can scale.
Human-in-the-loop validation · Audit traceability · Governed execution
Agentic AI deployment for governed clinical trial process.
Define Workflow
Identify the clinical workflow, systems, stakeholders, success criteria, and governance checkpoints before AI deployment begins.
Configure Agents
Set up purpose-built agents with SOPs, protocol context, sponsor standards, permissions, and human review thresholds.
Connect Systems
Integrate with EDC, CTMS, eTMF, safety, labs, metadata, and analytics environments without replacing core systems.
Validate Outputs
Test outputs against golden datasets, approved rules, clinical standards, and validation criteria before production use.
Supervise Execution
Agents execute defined steps, route exceptions, assign confidence signals, and keep human reviewers in control.
Scale Repeatable Patterns
Expand validated workflows across studies, functions, and therapeutic areas with monitoring, audit trails, and change control.
Maxis AI is delivered as a governed execution layer — designed to operate inside regulated environments rather than replace them.
Trust & safety controls for clinical AI in production.
Maxis AI is built to deploy clinical AI inside controlled environments, with secure data boundaries, human oversight, and audit-ready execution from the start.
Data Stays Controlled
Client data, study assets, and workflow context operate within isolated environments, with options for private cloud, customer cloud, or on-premise deployment.
Every Action Is Traceable
Agent activity, outputs, reviews, approvals, and changes can be logged with clear audit trails for governance and inspection readiness.
Humans Remain Accountable
AI agents execute defined workflow steps, while reviewers approve exceptions, validate critical outputs, and retain decision authority.
AI-enabled services aligned for regulated environments
CIOs / CDOs
Deploy compliant AI at enterprise scale.
Heads of Quality / RBQM
Advance predictive oversight without regulatory risk.
Digital Transformation Leaders
Operationalize AI with measurable ROI.
AI Innovation Leaders
Drive AI experimentation into governed, production-grade clinical workflows.
Where AI adoption stalls in clinical trials.
Most AI initiatives in regulated environments hit recurring blockers:
AI value is unlocked when execution is governed — not just intelligent.
- Pilots that never reach validated production use
- Point tools that don't integrate with EDC, CTMS, or eTMF
- Unclear audit trails and weak human oversight controls
- No path to align with GxP, 21 CFR Part 11, or SOC 2
- High change-management overhead on clinical teams
- Outcomes that aren't measurable against operational KPIs
What improves with AI-led delivery.
With governed AI services, execution is structured, traceable, and accountable:
Production-grade deployment inside live workflows
Native integration across clinical systems
Audit-ready logs across every agent action
Compliance alignment by design, not retrofit
Change-controlled rollout with no-code configuration
Measurable impact on cycle time and execution capacity
100+ Studies. Zero Regulatory Findings. GxP Validated. Board Approved.
AI adoption was moving fast. GxP governance needed to catch up. See how a global pharma improved validation consistency and inspection readiness.
208+
Live integrations
100%
Audit traceability
4
Compliance frameworks
0
Unsupervised actions
All You Need to Know
Maxis AI is delivered as a governed execution layer — agents run continuously inside live workflows with audit traceability, not as isolated experiments.
No. The integration layer connects with EDC, CTMS, eTMF, safety, and imaging platforms without rip-and-replace.
Every agent action is logged with full context, and human reviewers retain approval authority through defined supervision checkpoints.
GxP principles, 21 CFR Part 11, ICH-GCP standards, and SOC 2 Type II controls.
Yes. No-code deployment uses validated templates, role-based permissions, and change-controlled rollout aligned to your SOPs.
Explore the Agentic AI Platform.
See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.